发明授权
US5045553A Pharmaceutical composition for percutaneous drug absorption and
percutaneous drug absorption promoter
失效
用于经皮药物吸收和经皮药物吸收促进剂的药物组合物
- 专利标题： Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
- 专利标题（中）： 用于经皮药物吸收和经皮药物吸收促进剂的药物组合物
-
申请号： US208071申请日： 1988-06-17
-
公开(公告)号： US5045553A公开(公告)日： 1991-09-03
- 发明人: Yoshio Ueda , Takehisa Hata , Rinta Ibuki , Kazutake Kado , Hiroshi Ishikuro
- 申请人： Yoshio Ueda , Takehisa Hata , Rinta Ibuki , Kazutake Kado , Hiroshi Ishikuro
- 申请人地址： JPX Osaka
- 专利权人： Fujisawa Pharmaceutical Company, Ltd.
- 当前专利权人： Fujisawa Pharmaceutical Company, Ltd.
- 当前专利权人地址： JPX Osaka
- 优先权： JPX62-157234 19870624; JPX62-227113 19870910
- 主分类号： A61K31/455
- IPC分类号： A61K31/455 ; A61K9/00 ; A61K9/06 ; A61K9/08 ; A61K9/70 ; A61K31/44 ; A61K47/00 ; A61K47/10 ; A61K47/12 ; A61P9/08 ; A61P9/10 ; A61P9/12
摘要：
The present invention relates to a pharmaceutical composition for percutaneous drug absorption which comprises 5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and ethanol and/or an unsaturated higher fatty acid and to a composition of matter which comprises ethanol and/or an unsaturated higher fatty acid and is capable of promoting percutaneous absorption of said dihydropyridine compound.
公开/授权文献
- US4415198A Seat for invalid walker 公开/授权日：1983-11-15
信息查询
IPC分类:
